NUCLIDIUM AG, a clinical-stage radiopharmaceutical company, today announced that the first patient has been successfully imaged in a Phase 2 clinical trial evaluating the diagnostic accuracy and ...

PathMaker Neurosystems Inc. (“PathMaker”), a clinical-stage neurotechnology company developing a breakthrough non-invasive treatment for Amyotrophic Lateral Sclerosis (ALS, Lou Gehrig’s disease), ...

TORONTO, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Homebuyers were in a holding pattern in September, as uncertainty surrounding the economy, inflation and borrowing costs weighed on Greater Toronto Area (GTA ...

About ThinkEquity and The ThinkEquity Conference ThinkEquity LLC is a boutique investment bank providing a range of services to growth companies, including public and private capital raising, ...

Net income was US$20.49 million for the first half of fiscal year 2026, compared with a net loss of US$2.66 million in the same period of the prior year. This result was driven by a one-time, ...

Singapore, Singapore, October 6th, 2026, ChainwireThe invitation-only summit on October 8 brings 400 executives from banks, ...

Asset rotation accelerates: €260mn signed YTD at a 17% premium to GAV and a 42% gross margin, including a new €110mn JV – ...

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that its innovative CARTIHEAL AGILI-C ...

The single-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract carries a five-year ordering period and a maximum potential value of $14 million and represents an important opportunity for ...

YSX TECH. CO., LTD (NASDAQ: “YSXT”) (the “Company”), a Cayman Islands exempted company that, through its variable interest ...

Taking place October 6–7, WUBEN Prime Day 2026 gives members access to exclusive benefits, including: From pocket-sized EDC ...

Interim data from Phase I/II EMERALD study for RTX001, Resolution’s engineered Regenerative Macrophage Therapy, accepted as late-breaking ...